Amylx Pharmaceuticals Inc (AMLX) Stock Price Today
Aura AI Summary
Key Stats
- $2.16BMarket Cap
- -Volume
- HealthSector
- $19.5552W High
- $7.6452W Low
- -Typical Hold Time
- $1.89BEnterprise Value
- -Div Yield
- -Trading Activity
Track Amylx Pharmaceuticals Inc (AMLX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $7.64 and a high of $19.55, highlighting its annual price range. Buy and sell Amylx Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Most Recent News
Global AI in Medical Coding market to reach $10.6B by 2035 with 13.5% CAGR, driven by healthcare digital transformation.
The global AI in Medical Coding market, valued at $3 billion in 2025, is projected to grow to $10.6 billion by 2035 at a 13.5% CAGR. Growth is fueled by increasing adoption of AI technologies in healthcare for automated coding, fraud detection, and r...

Ecora Royalties reports 60% rise in Q2 2026 portfolio contribution, driven by base metals and debt reduction.
Ecora Royalties PLC announced a strong Q2 2026 trading update with total portfolio contribution rising by approximately 60% year-on-year to $19.0 million, mainly driven by a 166% increase in base metals contribution, especially cobalt from Voisey's B...

Royal Caribbean Cruises posts modest Q2 growth but strong bookings and solid dividends support optimism.
Royal Caribbean Cruises reported a 6.4% revenue growth in Q2 2026 despite rising fuel costs, with bookings at record levels supporting strong future guidance. The company slightly lowered its 2026 revenue growth forecast to 9%, but continues to offer...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.